<DOC>
	<DOCNO>NCT01521624</DOCNO>
	<brief_summary>Oxidative stress play key role pathogenesis diabetes complication . Chronic hyperglycemia disturb lipid regulation commonly see diabetes main cause process . Despite critical role oxidative stress diabetes , clinical trial available antioxidant vitamins either fail show long term benefit produce inconsistent result ( 10-11 ) . There grow interest establish possible role oral hypoglycemic agent include Metformin reduction oxidative stress . Metformin , common prescribe oral medication type 2 diabetes , lower HbA1c around 1.5 % , rarely cause hypoglycemia ( compare insulin sulfonylurea ) , relatively contraindication , adverse effect generally tolerable , cause weight gain , cheap , highly acceptable among patient . Given long term benefit observe metformin use , role modulate oxidative stress imputable . We design study evaluate action metformin oxidative stress group medication-na√Øve newly diagnose type 2 diabetes patient .</brief_summary>
	<brief_title>Metformin Effects Oxidative Stress Parameters Newly Diagnosed Type 2 Diabetes Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Newly diagnose type 2 diabetes patient base American Diabetes Association criterion diagnosis diabetes No history serious chronic illness heart , lung , kidney No prior treatment antidiabetes medication either diabetes condition associate hyperglycemia No intake prescribe overthecounter vitamin C E past year ; No intake aspirin past year No history excessive alcohol intake past year</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>